TB-500 to peptyd oparty na tymozynie 4 (T4)
rhNGF Clinical Investigator Group
In most cases, no peptide therapy and hormone replacement therapy serve different functions and are often used together rather than as substitutes for each other
Many Los Angeles patients compare these two options before booking
Trenkwalder C, Chaudhuri KR, Garca Ruiz PJ, LeWitt P, Katzenschlager R, Sixel-Dring F, et al
Potential Risks and Unknowns Because TB500 influences angiogenesis and cell proliferation , some researchers have raised theoretical concerns about: Promoting unwanted cell growth (e.g., in precancerous tissues) Interfering with natural inflammatory processes during healing Suppressing immune responses with long-term or high-dose use There is no conclusive evidence showing carcinogenicity, but as with any peptide that affects growth and regeneration, caution is warranted especially if theres a history of tumors or systemic disease